| Financial Year |
March 31 2023 |
| Monetary Funds |
56,975,004.30 |
| Held-for-trading Financial Assets |
23,299,988.64 |
| Notes Receivable |
54,024,324.40 |
| Accounts Receivable |
275,011,592.26 |
| Advances to Suppliers |
127,116,864.71 |
| Other Receivables |
13,494,884.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
430,655,049.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,137,346.58 |
| Total Current Assets |
1,002,806,740.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
233,060,525.61 |
| Investment Properties |
3,392,526.64 |
| Fixed Assetes |
289,398,208.66 |
| Under-construction Projects |
26,980,255.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
62,480,143.03 |
| R&D expenses |
-- |
| Goodwill |
294,484,985.72 |
| Long-Term Deferred and Prepaid Expenses |
8,657,086.32 |
| Deferred Income Tax Assets |
18,469,833.21 |
| Other Non-Current Assets |
9,659,291.70 |
| Sub-Total of Non-Current Assets |
957,422,214.38 |
| Total Assets |
1,960,228,954.66 |
| Short-Term Loans |
51,368,481.84 |
| Trading Financial liabilities |
-- |
| Notes Payable |
21,038,898.70 |
| Accounts Payable |
111,289,996.94 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,226,126.94 |
| Taxes Payable |
8,828,021.63 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
20,297,479.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
56,080,301.06 |
| Other Current Liabilities |
2,037,262.59 |
| Sub-Total of Current Liabilities |
290,927,305.18 |
| Long-term Loans |
97,477,544.10 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
125,120,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,933,783.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
291,839,923.22 |
| Total Liabilities |
582,767,228.40 |
| Paid-In Capital(Or Share Stock) |
240,000,000.00 |
| Capital Surplus |
433,262,776.20 |
| Surplus Reserve |
69,399,739.90 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
415,551,675.09 |
| Minority Stockholder's Interest |
219,606,511.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,157,855,214.88 |
| Owner's Equity（Stockholder's Equity） |
1,377,461,726.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,960,228,954.66 |
